The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting

Background/Aims: The most common cancer among men and the third most common among women in Saudi Arabia is colon cancer. This study aimed to evaluate the yield of the fecal occult blood test (FOBT) used as a screening tool for colon cancer. Settings and Design: Medical records of all patients above...

Full description

Bibliographic Details
Main Authors: Naif M Almoneef, Abdullah H Alkhenizan, Ahmed S Mahmoud, Suad A Alsoghayer, Abdulaziz A Aldheshe
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=8;spage=4435;epage=4439;aulast=Almoneef
_version_ 1798021776414867456
author Naif M Almoneef
Abdullah H Alkhenizan
Ahmed S Mahmoud
Suad A Alsoghayer
Abdulaziz A Aldheshe
author_facet Naif M Almoneef
Abdullah H Alkhenizan
Ahmed S Mahmoud
Suad A Alsoghayer
Abdulaziz A Aldheshe
author_sort Naif M Almoneef
collection DOAJ
description Background/Aims: The most common cancer among men and the third most common among women in Saudi Arabia is colon cancer. This study aimed to evaluate the yield of the fecal occult blood test (FOBT) used as a screening tool for colon cancer. Settings and Design: Medical records of all patients above the age of 50 years who had visited the Family Medicine clinic at King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia and who had undergone the FOBT screening between January 2002 and March 2017 were retrospectively reviewed. Materials and Methods: We collected patients' demographic data, FOBT results, and colonoscopy pathology reports results. Statistical Analysis: Data were analyzed using the Statistical Package for Social Science Version 25 (IBM Corp., Armonk, NY, USA). Results: We included 2179 patients in this study. The mean age was 59.8 ± 8 years. As a result of the FOBT screening, 19.7% of the patients had a positive FOBT. Colon cancer accounted for 3.5% of all abnormal colonoscopy pathology reports. The Saudi age-standardized incidence rate (ASIR) in our study was 26.56 per 100,000 persons. Conclusion: FOBT is a feasible tool that can be used for colon cancer screening in primary care settings. The Saudi ASIR in our study was higher than the Saudi Cancer Registry, but it was still lower in comparison to other countries. We recommend the establishment of a national community-based colon cancer screening program.
first_indexed 2024-04-11T17:19:05Z
format Article
id doaj.art-6f7c571faced43e690a8b2ae979ae1d4
institution Directory Open Access Journal
issn 2249-4863
language English
last_indexed 2024-04-11T17:19:05Z
publishDate 2022-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Family Medicine and Primary Care
spelling doaj.art-6f7c571faced43e690a8b2ae979ae1d42022-12-22T04:12:32ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632022-01-011184435443910.4103/jfmpc.jfmpc_16_22The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care settingNaif M AlmoneefAbdullah H AlkhenizanAhmed S MahmoudSuad A AlsoghayerAbdulaziz A AldhesheBackground/Aims: The most common cancer among men and the third most common among women in Saudi Arabia is colon cancer. This study aimed to evaluate the yield of the fecal occult blood test (FOBT) used as a screening tool for colon cancer. Settings and Design: Medical records of all patients above the age of 50 years who had visited the Family Medicine clinic at King Faisal Specialist Hospital and Research Centre in Riyadh, Saudi Arabia and who had undergone the FOBT screening between January 2002 and March 2017 were retrospectively reviewed. Materials and Methods: We collected patients' demographic data, FOBT results, and colonoscopy pathology reports results. Statistical Analysis: Data were analyzed using the Statistical Package for Social Science Version 25 (IBM Corp., Armonk, NY, USA). Results: We included 2179 patients in this study. The mean age was 59.8 ± 8 years. As a result of the FOBT screening, 19.7% of the patients had a positive FOBT. Colon cancer accounted for 3.5% of all abnormal colonoscopy pathology reports. The Saudi age-standardized incidence rate (ASIR) in our study was 26.56 per 100,000 persons. Conclusion: FOBT is a feasible tool that can be used for colon cancer screening in primary care settings. The Saudi ASIR in our study was higher than the Saudi Cancer Registry, but it was still lower in comparison to other countries. We recommend the establishment of a national community-based colon cancer screening program.http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=8;spage=4435;epage=4439;aulast=Almoneefcolon cancercolonic polypscolonoscopyfobtsaudi arabiascreening
spellingShingle Naif M Almoneef
Abdullah H Alkhenizan
Ahmed S Mahmoud
Suad A Alsoghayer
Abdulaziz A Aldheshe
The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting
Journal of Family Medicine and Primary Care
colon cancer
colonic polyps
colonoscopy
fobt
saudi arabia
screening
title The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting
title_full The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting
title_fullStr The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting
title_full_unstemmed The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting
title_short The yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting
title_sort yield of fecal occult blood testing as a screening tool for colon cancer in a primary care setting
topic colon cancer
colonic polyps
colonoscopy
fobt
saudi arabia
screening
url http://www.jfmpc.com/article.asp?issn=2249-4863;year=2022;volume=11;issue=8;spage=4435;epage=4439;aulast=Almoneef
work_keys_str_mv AT naifmalmoneef theyieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting
AT abdullahhalkhenizan theyieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting
AT ahmedsmahmoud theyieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting
AT suadaalsoghayer theyieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting
AT abdulazizaaldheshe theyieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting
AT naifmalmoneef yieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting
AT abdullahhalkhenizan yieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting
AT ahmedsmahmoud yieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting
AT suadaalsoghayer yieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting
AT abdulazizaaldheshe yieldoffecaloccultbloodtestingasascreeningtoolforcoloncancerinaprimarycaresetting